Novo Nordisk A/S (NYSE:NVO) Posts Basic Consolidated EPS Of $1.8013

0

Novo Nordisk A/S (NYSE:NVO)managed to report annual basic consolidated EPS of $1.8013, which was for the year ended2014-12-31.The company reported basic consolidated EPS of $1.8013 for the quarter ended 2014-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2014-12-31. As for the quarter ended 2014-12-31, continuing operations produced EPS of $0.597.

EPS contribution from parent

Novo Nordisk A/S (NYSE:NVO) received of $1.8013 EPS boost from the parent company for the annual period ended

For the year ended 2014-12-31, the parent of Novo Nordisk A/S (NYSE:NVO) contributed EPS of $1.8013 to the company’s bottom-line. But for the quarter ended 2014-12-31, EPS boost from the parent was cited as $1.8013.

What About Basic net EPS

The basic net EPS that Novo Nordisk A/S (NYSE:NVO) reported for the year ended 2014-12-31 stood at $1.8008. For the quarter ended 2014-12-31, the company posted basic net EPS of $1.8008.

What About Consolidated Diluted EPS?

Novo Nordisk A/S (NYSE:NVO)’s consolidated diluted EPS for the year ended 2014-12-31 was reported as $1.7951. For the quarter ended 2014-12-31 the metric was$1.7951.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $1.7951 for the yearended 2014-12-31. But diluted EPS from continuing operations for the quarter ended 2014-12-31 came in at $1.7951.

Net diluted EPS

Net diluted EPS posted by Novo Nordisk A/S (NYSE:NVO) for the year ended 2014-12-31 was $1.7955. On quarterly basis, net diluted EPS for the quarter ended 2014-12-31 was reported as $1.7955.

What portion of diluted EPS came from parent?

For the annual period ended 2014-12-31, the parent company of Novo Nordisk A/S (NYSE:NVO) said that it parent company boosted its diluted EPS by$1.7951 in the year ended 2014-12-31. For the quarter ended 2014-12-31, the parent company’s contribution to diluted EPS was $1.7951.

The company reported net basic EPS of $2.02 for the year ended 2014-12-31 and net basic EPS of $2.02 for the quarter ended 2014-12-31.

The number of Novo Nordisk A/S (NYSE:NVO)’s basic shares outstanding at the end of the annual period ended 2014-12-31 was 2570.796. That compares with 2570.796 basic shares outstanding for the quarter ended 2014-12-31.

Novo Nordisk A/S (NYSE:NVO) had 2570.796 diluted shares outstanding at the end of the annual period ended 2014-12-31. But for the quarter ended 2014-12-31, diluted outstanding shares were 2570.796.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 32 times, 1 visits today)